Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Orally active, selective V2 agonists in development at AHP

March 12, 1999

Recordati claims potent and selective 5-HT1A receptor antagonists for urinary disorders

March 12, 1999

New Drug Submission for Ditropan accepted for review in Canada

March 10, 1999

Microbially produced 5alpha-reductase inhibitor discovered at Snow Brand

March 9, 1999

Licensing opportunity from VUFB: alpha2-adrenoceptor antagonist for BPH and heart failure

Feb. 16, 1999

PKC inhibitors designed at Otsuka

Feb. 9, 1999

Alza launches Ditropan XL in the U.S.

Feb. 3, 1999

Chugai patents 2,3-dihydrobenzofurans with cytoprotective effects

Jan. 27, 1999

Oral L-arginine compared to placebo for efficacy in interstitial cystitis

Jan. 25, 1999

Therapeutic advantages of paricalcitol further defined

Jan. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...